By their very definition, stages of cancer refer to the difficulty in eliminating the tumor(s) from the body. But they are not a hard and fast number; rather, they're an indication of how far the cancer has spread.
Some people diagnosed with Stage 1 cancer never recover; while a lucky few who have reached Stage 4 respond miraculously well to treatment. But in general, your best chance of survival is to catch the disease while its still in stages I or II; anything beyond that will almost certainly require major organ-removal surgery, plus painful follow-up therapies such as radiation and chemo.
The survival rate at one year after transplant was 77% for lung transplants and 64% for heart-lung transplants
Yes, it is possible for someone with lung cancer to live for nine years or longer, depending on various factors such as the stage of the cancer at diagnosis, the type of lung cancer, treatment options, and individual health. Advances in treatment, including targeted therapies and immunotherapy, have improved survival rates for many patients. Regular monitoring and a personalized treatment plan can also contribute to longer survival times. Each case is unique, so outcomes can vary significantly.
Yes, lung cancer can recur after a lobectomy, which is a surgical procedure to remove a lobe of the lung. While lobectomy can significantly reduce the risk of cancer progression and improve survival rates, it does not guarantee that cancer will not return. Factors such as the type and stage of the original cancer, as well as individual patient characteristics, can influence the likelihood of recurrence. Regular follow-up and monitoring are essential for early detection of any potential return of the disease.
Lung cancer is often associated with smoking, and the incidence and mortality rates are influenced by tobacco use. Other common causes of cancer-related deaths in the U.S. include colorectal cancer, breast cancer (among women), and prostate cancer (among men).
In each of the major racial/ethnic groups in the United States, the rates of lung cancer among men are about two to three times greater than the rates among women.
While relatively rare, once diagnosed, pancreatic cancer has just a 5% 5 year survival rate, which is the lowest survival rate of cancer at any site location (lung cancer is next at 15%).
indonesia
It takes many years of smoking to cause lung cancer.
nicotine.
Thyroid cancer is generally associated with very high survival rates. The prognosis for thyroid cancer is often favorable, with the majority of patients surviving the disease. Survival rates can vary depending on the specific type and stage of thyroid cancer. Here are some general survival rate statistics: Papillary Thyroid Cancer: Papillary thyroid cancer, the most common type, has a high survival rate. The 5-year relative survival rate for localized papillary thyroid cancer is approximately 99%, meaning that almost all patients with localized disease are alive 5 years after diagnosis. Even for regional (spread to nearby lymph nodes) or distant (metastatic) disease, the 5-year survival rate remains relatively high at around 93%. Follicular Thyroid Cancer: Follicular thyroid cancer also has favorable survival rates. The 5-year relative survival rate for localized disease is approximately 97%. For regional disease, it's about 86%, and for distant disease, it's around 67%. Medullary Thyroid Cancer: Medullary thyroid cancer has slightly lower survival rates compared to papillary and follicular types. For localized disease, the 5-year relative survival rate is around 98%. For regional disease, it's about 89%, and for distant disease, it drops to approximately 41%. Anaplastic Thyroid Cancer: Anaplastic thyroid cancer is the most aggressive form of thyroid cancer, and survival rates are much lower. The 5-year relative survival rate for this type is generally less than 10%, and many cases are fatal.
Colon cancer survival rates vary greatly depending on which stage the cancer is in when diagnosed. On average, a typical 5-year survival rate is between 55% and 63%.
We have known for a long time that the survival rate for men with lung cancer is lower than it is for women. On the other hand, the good news is the death rate for lung cancer in men (unlike women) has been dropping in recent years.